CoreWeave Announces Date of Second Quarter 2025 Financial Results
23 juli, 22:05
23 juli, 22:05
CoreWeave, Inc. (Nasdaq: CRWV) announced today that it will release second quarter 2025 financial results, after the market closes on Tuesday, August 12, 2025.
CoreWeave will also host a conference call to discuss its results at 2:00 pm Pacific Time / 5:00 pm Eastern Time. The live webcast of the earnings conference call can be accessed at the CoreWeave Investor Relations website at investors.coreweave.com. A replay of the webcast will be available at the same website.
About CoreWeave, Inc.
CoreWeave, the AI Hyperscaler™, delivers a cloud platform of cutting-edge software powering the next wave of AI. The company's technology provides enterprises and leading AI labs with cloud solutions for accelerated computing. Since 2017, CoreWeave has operated a growing footprint of data centers across the US and Europe. Learn more at www.coreweave.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250723855317/en/
23 juli, 22:05
CoreWeave, Inc. (Nasdaq: CRWV) announced today that it will release second quarter 2025 financial results, after the market closes on Tuesday, August 12, 2025.
CoreWeave will also host a conference call to discuss its results at 2:00 pm Pacific Time / 5:00 pm Eastern Time. The live webcast of the earnings conference call can be accessed at the CoreWeave Investor Relations website at investors.coreweave.com. A replay of the webcast will be available at the same website.
About CoreWeave, Inc.
CoreWeave, the AI Hyperscaler™, delivers a cloud platform of cutting-edge software powering the next wave of AI. The company's technology provides enterprises and leading AI labs with cloud solutions for accelerated computing. Since 2017, CoreWeave has operated a growing footprint of data centers across the US and Europe. Learn more at www.coreweave.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250723855317/en/
Fonder
Konjunktur
Novo Nordisk
Aktieråd
Analys
Fonder
Konjunktur
Novo Nordisk
Aktieråd
Analys
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 566,53